3-间甲苯氧基苯胺 | 116289-59-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-间甲苯氧基苯胺
• 英文名称: 3-(3-methylphenoxy)aniline
• 英文别名: 3-m-tolyloxy-aniline；3-m-Tolyloxy-anilin
• CAS: 116289-59-9
• 化学式: C₁₃H₁₃NO
• 分子量: 199.252
• InChiKey: MQHARMNTKNAABO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-间甲苯氧基苯胺 在 三乙基硅烷 、 4 Angstroem MS 、 三乙酰氧基硼氢化钠 、 溶剂黄146 、 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 生成 N-[(2R)-2-amino-3-mercaptopropyl]amino-3-[(3-methylphenyl)oxy]benzene
  参考文献：
  名称：

  DIARYLETHER INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE

  摘要：

  The design and synthesis of simple nonpeptide inhibitors of farnesyl-protein transferase (FTase) are described. Cysteine-derived diarylether frameworks are appropriate structural replacements for the C-terminal tetrapeptide portion of the Ras protein, and possess in vitro potency against FTase. Inhibitory activity is dependent on the ring-substitution pattern, and does not require the presence of a C-terminal carboxylate group. (C) 1997 Elsevier Science Ltd.

  DOI：

  10.1016/s0960-894x(97)00225-4
• 作为产物：
  描述：

  1-methyl-3-(3-nitrophenoxy)benzene 在 铁粉 、 溶剂黄146 作用下， 以 甲醇 为溶剂， 生成 3-间甲苯氧基苯胺
  参考文献：
  名称：

  DIARYLETHER INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE

  摘要：

  The design and synthesis of simple nonpeptide inhibitors of farnesyl-protein transferase (FTase) are described. Cysteine-derived diarylether frameworks are appropriate structural replacements for the C-terminal tetrapeptide portion of the Ras protein, and possess in vitro potency against FTase. Inhibitory activity is dependent on the ring-substitution pattern, and does not require the presence of a C-terminal carboxylate group. (C) 1997 Elsevier Science Ltd.

  DOI：

  10.1016/s0960-894x(97)00225-4

文献信息

• [EN] HETEROCYCLIC COMPOUNDS FOR MODULATING NR2F6<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES POUR LA MODULATION DE NR2F6
  申请人：TES PHARMA S R L

  公开号：WO2021170658A1

  公开（公告）日：2021-09-02

  The present disclosure relates to compounds capable of modulating the activity of NR2F6. The compounds of the disclosure may be used in methods for the prevention and/or the treatment of diseases and disorders associated with modulating NR2F6 activity.

  本公开涉及能够调节NR2F6活性的化合物。本公开的化合物可用于预防及/或治疗与调节NR2F6活性相关疾病和障碍的方法。
• EPOXY COMPOUND AND MANUFACTURING METHOD THEREOF
  申请人：Ono Koutaro

  公开号：US20110040111A1

  公开（公告）日：2011-02-17

  A novel epoxy compound represented by the following formula and a method for producing the same are provided: wherein R 1 and R 2 are members selected from the group consisting of hydrogen, aliphatic hydrocarbon group having 1 to 4 carbon atoms, alicyclic hydrocarbon group having 3 to 6 carbon atoms, aromatic hydrocarbon group having 6 to 10 carbon atoms, halogen atom, ether group, ester group, acyl group and nitro group, n is an integer of 1 to 4, and m is an integer of 1 to 5.

  提供了一种由以下式表示的新型环氧化合物及其制备方法：其中R1和R2是从氢、具有1至4个碳原子的脂肪烃基、具有3至6个碳原子的脂环烃基、具有6至10个碳原子的芳香烃基、卤原子、醚基、酯基、酰基和硝基组成的群体中选择的成员，n是1至4的整数，m是1至5的整数。
• INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE
  申请人：MERCK & CO., INC.

  公开号：EP0817629A1

  公开（公告）日：1998-01-14
• EP0817629A4
  申请人：——

  公开号：EP0817629A4

  公开（公告）日：2000-03-08
• HETEROCYCLIC COMPOUNDS FOR MODULATING NR2F6
  申请人：TES Pharma S.r.l.

  公开号：US20210323942A1

  公开（公告）日：2021-10-21

  The present disclosure relates to compounds capable of modulating the activity of NR2F6. The compounds of the disclosure may be used in methods for the prevention and/or the treatment of diseases and disorders associated with modulating NR2F6 activity.